Sino Biopharm (P Chi Dividend yield

 Price  6.46
 Dividend  0.10
 Earnings  0.21
 Cash-flow  0.34
 Book value  1.06
 Equity  1.44

Sino Biopharm (P Chi is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Sino Biopharm (P Chi is a company from China, and his stocks are publicly traded.

Sino Biopharm (P Chi paid a total dividend of 1,886 million HKD last year, for a market value of 121,849 millions (Market Cap 62,916 millions). Dividend per share of Sino Biopharm (P Chi is 0.10 HKD, and his stock market price 6.46 HKD.

According to the chart below, where dividend yield is displayed, Sino Biopharm (P Chi has a dividend yield of 1.55%, which is lower than the amount offered by the market average , but bigger than Health Care industry. Dividend yields are similar among companies from the same industry, so it is a positive sign for the company.

In addition, you should compare Sino Biopharm (P Chi dividend yield with other Pharmaceuticals and Biotechnology companies or firms from China.

Dividend yield of Sino Biopharm (P Chi

Sino Biopharm (P Chi Dividend Payout

About the ability of Sino Biopharm (P Chi to maintain his current dividend of HKD 0.10 per share, an amount that accounts for 1.55%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Sino Biopharm (P Chi payout on ernings is currently 47.62%, which is higher than the market average, and companies of Health Care industry, which are 39.27% and 31.41% respectively. Both figures show that Sino Biopharm (P Chi can have problems to keep with his present dividend yield.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Sino Biopharm (P Chi is HKD 0.34 per share, which is higher than the dividend per share paid by the company of HKD 0.10, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Sino Biopharm (P Chi, compared againt world market average, China companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Sino Biopharm (P Chi payout

Sino Biopharm (P Chi Dividend History

Year Yield  HKD  Paypout  Shares* 

*In millions

Sino Biopharm (P Chi Stock performance

Finally, last moth Sino Biopharm (P Chi showed a return of -0.80% compared to a worldwide -1.33% average, and a -3.33% of Health Care firms. Over the last year, the company obtained a -23.50% versus a worldwide performance of a 31.58%. More detailed information can be seen in the following graph for China and Pharmaceuticals and Biotechnology firms.

Sino Biopharm (P Chi stock and market return